Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Hooker

Showing results (111-120 of 153) with videos related to

Pageof 16
Sort By:
Medrxiv : the Preprint Server for Health Sciences|November 11, 2020
Profiling SARS-CoV-2 mutation fingerprints that range from the viral pangenome to individual infection quasispeciesBilly T Lau, Dmitri Pavlichin, Anna C Hooker, et al.
Statistics in Medicine|February 20, 2025
A Comparison of Statistical Methods for Time-To-Event Analyses in Randomized Controlled Trials Under Non-Proportional HazardsFlorian Klinglmüller, Tobias Fellinger, Franz König, et al.
Clinical Pharmacology and Therapeutics|January 10, 2008
Population pharmacokinetic model for docetaxel in patients with varying degrees of liver function: incorporating cytochrome P4503A activity measurementsA C Hooker, A J Ten Tije, M A Carducci, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|October 6, 2018
LI-RADS Version 2018 Ancillary Features at MRIMilena Cerny, Victoria Chernyak, Damien Olivié, et al.
Abdominal Radiology (New York)|October 1, 2016
Agreement between region-of-interest- and parametric map-based hepatic proton density fat fraction estimation in adults with chronic liver diseasePaul M Manning, Gavin Hamilton, Kang Wang, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 27, 2024
A fully automatic tool for development of population pharmacokinetic modelsXiaomei Chen, Rikard Nordgren, Stella Belin, et al.
Hepatology (Baltimore, Md.)|December 23, 2014
Magnetic resonance imaging and liver histology as biomarkers of hepatic steatosis in children with nonalcoholic fatty liver diseaseJeffrey B Schwimmer, Michael S Middleton, Cynthia Behling, et al.
Genome Medicine|April 20, 2021
Profiling SARS-CoV-2 mutation fingerprints that range from the viral pangenome to individual infection quasispeciesBilly T Lau, Dmitri Pavlichin, Anna C Hooker, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 5, 2025
A Pharmacometrics-Informed Trial Simulation Framework for Optimizing Study Designs for Disease-Modifying Treatments in Rare Neurological DisordersYevgen Ryeznik, Ralf-Dieter Hilgers, Nicole Heussen, et al.
Journal of Magnetic Resonance Imaging : JMRI|August 30, 2017
MRI proton density fat fraction is robust across the biologically plausible range of triglyceride spectra in adults with nonalcoholic steatohepatitisCheng William Hong, Adrija Mamidipalli, Jonathan C Hooker, et al.
Pageof 16

Showing results (111-120 of 153) with videos related to

Sort By:
Pageof 16
Medrxiv : the Preprint Server for Health Sciences|November 11, 2020
Profiling SARS-CoV-2 mutation fingerprints that range from the viral pangenome to individual infection quasispeciesBilly T Lau, Dmitri Pavlichin, Anna C Hooker, et al.
Statistics in Medicine|February 20, 2025
A Comparison of Statistical Methods for Time-To-Event Analyses in Randomized Controlled Trials Under Non-Proportional HazardsFlorian Klinglmüller, Tobias Fellinger, Franz König, et al.
Clinical Pharmacology and Therapeutics|January 10, 2008
Population pharmacokinetic model for docetaxel in patients with varying degrees of liver function: incorporating cytochrome P4503A activity measurementsA C Hooker, A J Ten Tije, M A Carducci, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|October 6, 2018
LI-RADS Version 2018 Ancillary Features at MRIMilena Cerny, Victoria Chernyak, Damien Olivié, et al.
Abdominal Radiology (New York)|October 1, 2016
Agreement between region-of-interest- and parametric map-based hepatic proton density fat fraction estimation in adults with chronic liver diseasePaul M Manning, Gavin Hamilton, Kang Wang, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 27, 2024
A fully automatic tool for development of population pharmacokinetic modelsXiaomei Chen, Rikard Nordgren, Stella Belin, et al.
Hepatology (Baltimore, Md.)|December 23, 2014
Magnetic resonance imaging and liver histology as biomarkers of hepatic steatosis in children with nonalcoholic fatty liver diseaseJeffrey B Schwimmer, Michael S Middleton, Cynthia Behling, et al.
Genome Medicine|April 20, 2021
Profiling SARS-CoV-2 mutation fingerprints that range from the viral pangenome to individual infection quasispeciesBilly T Lau, Dmitri Pavlichin, Anna C Hooker, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 5, 2025
A Pharmacometrics-Informed Trial Simulation Framework for Optimizing Study Designs for Disease-Modifying Treatments in Rare Neurological DisordersYevgen Ryeznik, Ralf-Dieter Hilgers, Nicole Heussen, et al.
Journal of Magnetic Resonance Imaging : JMRI|August 30, 2017
MRI proton density fat fraction is robust across the biologically plausible range of triglyceride spectra in adults with nonalcoholic steatohepatitisCheng William Hong, Adrija Mamidipalli, Jonathan C Hooker, et al.
Pageof 16